Vigne P, Jean T, Barbry P, Frelin C, Fine L G, Lazdunski M
J Biol Chem. 1985 Nov 15;260(26):14120-5.
[3H]Ethylpropylamiloride is a useful radioactive label to identify the Na+/H+ exchange system (Vigne, P., Frelin, C., Audinot, M., Borsotto, M., Cragoe, E. J., and Lazdunski, M. (1984) EMBO J. 3, 2647-2651). This paper extends the analysis of the properties of interaction of [3H]ethylpropylamiloride with the exchanger and describes its use with hypertrophied kidneys. [3H]Ethylpropylamiloride-binding sites copurify with the luminal membrane marker alkaline phosphatase but not with the basolateral membrane marker (Na+,K+)ATPase, thus indicating an asymmetric distribution of the Na+/H+ exchanger. Specific [3H]ethylpropylamiloride binding is dependent on pH. The pH dependency indicates that an ionizable function with a pKapp of 7.0 is essential in the association of the amiloride derivative. H+ acts competitively on [3H]ethylpropylamiloride binding; Na+, Li+, or cholinium ions have no effect on the association. Compensatory adaptation of the kidney to chronic reduction of renal mass is accompanied by a 1.7-fold increase in the activity of the Na+/H+ exchange system. Properties of interaction of internal and external pH with the Na+/H+ exchanger of normal and hypertrophied kidneys are identical. Titration of [3H]ethylpropylamiloride-binding sites in normal and hypertrophied kidneys suggests that the increased activity of the Na+/H+ exchange system is not accompanied by an increased concentration of exchangers.
[3H]乙基丙基氨氯吡脒是一种用于识别Na+/H+交换系统的有用放射性标记物(维涅,P.,弗雷林,C.,奥迪诺,M.,博尔索托,M.,克拉戈伊,E.J.,和拉兹敦斯基,M.(1984年)《欧洲分子生物学组织杂志》3,2647 - 2651)。本文扩展了对[3H]乙基丙基氨氯吡脒与该交换器相互作用特性的分析,并描述了其在肥大肾脏中的应用。[3H]乙基丙基氨氯吡脒结合位点与腔面膜标记物碱性磷酸酶共纯化,但不与基底外侧膜标记物(Na+,K+)ATP酶共纯化,因此表明Na+/H+交换器存在不对称分布。特异性[3H]乙基丙基氨氯吡脒结合依赖于pH。pH依赖性表明,一个表观pK为7.0的可电离功能在氨氯吡脒衍生物的结合中至关重要。H+对[3H]乙基丙基氨氯吡脒结合起竞争性作用;Na+、Li+或胆碱离子对结合无影响。肾脏对肾质量慢性减少的代偿性适应伴随着Na+/H+交换系统活性增加1.7倍。正常和肥大肾脏中内部和外部pH与Na+/H+交换器相互作用的特性相同。对正常和肥大肾脏中[3H]乙基丙基氨氯吡脒结合位点的滴定表明,Na+/H+交换系统活性的增加并未伴随着交换器浓度的增加。